glp-1 news updates november 2025 Agonists Weight Loss Drugs Market Report, 2025-2030 GLP-1 Receptor Agonist Market to

Lose It is built for the general calorie-counter job: calorie budgets, meal logging, macros, fasting, meal planning, community, and broad nutrition tracking

10.1016/j.ejphar.2019.172715 130 YuM.WangR.PeiL.ZhangX.WeiJ.WenY.et al (2023)

There's no human safety data supporting year-round use

There is some evidence suggesting that GLP-1RA may accelerate skin aging by targeting cells in the adipose tissue layer and inhibiting their proliferation and metabolic activity

Autoregenerative redox nanoparticles as an antioxidant and glycation inhibitor for palliation of diabetic cataracts

Studies are planned to further evaluate NPI-001 and NPI-002 as potential treatments for AMD and Stargardt disease